Phase III, Placebo-Controlled Trial of Three Doses of Citalopram for the Treatment of Hot Flashes: NCCTG Trial N05C9

PURPOSE: Up to 75% of women experience hot flashes, which can negatively impact quality of life. As hot flash physiology is not definitively understood, it cannot be assumed that effective agents represent class effects. Therefore, there is a continued need for rigorous evaluation to identify effect...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Barton, Debra L., LaVasseur, Beth I., Sloan, Jeff A., Stawis, Allen N., Flynn, Kathleen A., Dyar, Missy, Johnson, David B., Atherton, Pamela J., Diekmann, Brent, Loprinzi, Charles L.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: American Society of Clinical Oncology 2010
विषय:
Original Reports
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC2903326/
https://ncbi.nlm.nih.gov/pubmed/20498389
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.26.6379
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन